What is it about?
Helmut Baumgartner MD, chair of the ESC task force for the management of valvular heart disease talks about the changes to the updated Guidelines presented in August 2017 at the ESC Congress in Barcelona.
Photo by Aron Visuals on Unsplash
Why is it important?
The wealth of new data accumulated during the period since 2012, particularly on percutaneous interventional techniques, has required an urgent update of the previous Guidelines.
Read the Original
This page is a summary of: ESC Clinical Practice Guidelines on the Management of Valvular Heart Disease-2017 Update, European Heart Journal, September 2017, Oxford University Press (OUP), DOI: 10.1093/eurheartj/ehx470.
You can read the full text:
The following have contributed to this page